TITLE

German drugs researchers face axe

AUTHOR(S)
Gibson, Jane
PUB. DATE
January 2007
SOURCE
ICIS Chemical Business;1/29/2007, Vol. 2 Issue 51, p12
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article unveils the plan of German drug makers to reduce their workforce in 2007. The plans were raised in relation to the expected lower sales and earnings in the country. According to a survey, several companies will reduce their research and development (R&D) spending. Another study concluded that staff reductions in the country's drugs sector is related to the global industry consolidation and changing job profiles.
ACCESSION #
23977789

 

Related Articles

  • 12 Tips for Discussing Position Elimination or Downsizing. Sundvall, Cathy // Orthodontic Products;Mar2009, Vol. 16 Issue 2, p16 

    The article cites the 12 tips on how to discuss position elimination or downsizing within the American industry. The strategies include quick and simple conversation, held talks in private locations, emphasize the importance of changes in the practice that includes the elimination of one...

  • Lilly braces for plunge in profits. Wall, J. K. // Indianapolis Business Journal;8/16/2010, Vol. 31 Issue 24, p1 

    The article reports on the efforts of pharmaceutical company Eli Lilly & Co. to prepare for the projected decline in profits. The author mentions that the company is facing expirations of several drug patents and loss of revenue. One analyst forecasts that the company will lose 4.3 billion...

  • Top merchanting chains profits tumble.  // Builders Merchants Journal;Oct2008, p5 

    The article forecasts the decline of Wolseley PLC's full-year profits to July 31, 2008 at 77% as compared in 2007 in Great Britain. Data shows that the company's pre-tax profits fell to £145 million while its trading profit was 16.6% lower at £176 million. It made 7,100 job cuts throughout...

  • Rigel Cuts Staff 20%, Delays Partner Talks.  // BioWorld Today;2/4/2009, Vol. 20 Issue 22, p2 

    The article reports that Rigel Pharmaceuticals Inc. is reducing 36 employees from its payroll, or 20 percent of its work force, to conserve cash as it focuses on its lead product candidate. The downsizing will come in the virology and oncology research programs of Rigel, and are aimed at bulking...

  • ACTELION LTD.  // MondayMorning;7/16/2012, Vol. 20 Issue 28, p1 

    The article reports on the plan of Actelion Ltd. to cut 135 jobs in Allschwil, Switzerland. Actelion also plans to refocus research on rare diseases and specialty pharmaceuticals as sales decline for the company's best-selling product, the Tracleer blood -pressure drug. The company is said to...

  • Pharmaceutical giants to slash 13,000 jobs.  // Professional Engineering;2/7/2007, Vol. 20 Issue 3, p5 

    The article reports on the plan of pharmaceutical companies AstraZeneca PLC and Pfizer Inc. to cut jobs in Great Britain. AstraZenca will be slashing 3,000 jobs in the production area over the next three years while Pfizer will be laying off 10,000 jobs globally over the next two years....

  • Belts getting tighter.  // Pharmaceutical Representative;Apr2009, Vol. 39 Issue 4, p7 

    The article focuses on the retrenchment of several employees in pharmaceutical industry in the U.S. due to the impact of the global economic recession. An overview of pharmaceutical companies which rendered downsizing of employees are provided which includes Trubion Pharmaceuticals, Panacos...

  • Novacea Slashing Jobs Following Ill-Fated Trial. Hollingsworth, Catherine // BioWorld Today;5/14/2008, Vol. 19 Issue 94, p1 

    The article reports on the plan of Novacea to reduce its workforce to about 15 employees, as it faces a net loss of $1.2 million for the first quarter of 2008. The job cuts come about after Schering-Plough Corp. ended its collaboration agreement with Novacea to develop Asentar for prostate...

  • Do's and Don'ts of Downsizing. Grant, Susan; Cherkis, Carol // Pharmaceutical Executive;May2003, Vol. 23 Issue 5, p102 

    Reports on the importance of business planning in handling corporate downsizing among pharmaceutical companies in the U.S. Advantage of positive industrial relations; Preparation for employee retrenchment; Executive training to conduct layoffs. INSETS: Step by Step;Breaking the News.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics